Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Food and Drug Administration Reform Act of 2012
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Prescription Drug User Fee Act reauthorization. Product exclusivity issues; pedigree issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY via MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
2012 · second_quarter · Q2
FY 2013 budget resolution. H. Con.Res 112, Establishing the budget for the US Government for FY 2013 H.R. 5973/S.2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Medicare coverage and reimbursement. H. Con. Res 112, Establishing the budget for the US Government for FY 2013.
Source: Senate LDA
FY 2013 budget resolution. H. Con.Res 112, Establishing the budget for the US Government for FY 2013 H.R. 5973/S.2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Continuing Appropriations Act, 2012
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Medicare coverage and reimbursement. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67 H.R.2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011.
Continuing Appropriations Act, 2012
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
FY 2012 Budget resolutions H.R. 2017, Continuing Appropriations Act, 2012. H.R. 2608, Continuing Appropriations Act, 2012. S. 365/Pub. L. 112-25, Budget Control Act of 2011.
Continuing Appropriations Act, 2012
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
340B-related issues. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68 H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2674, 340B Program Improvement Act Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Continuing Appropriations Act, 2012
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
FY 2012 budget resolutions. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68 H.J.RES. 94, Continuing Resolution throuh 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. . 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
Continuing Appropriations Act, 2012
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
340B-related issues. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68 H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2674, 340B Program Improvement Act Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Continuing Appropriations Act, 2012
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Medicare coverage and reimbursement. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67 H.R.2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011.
Continuing Appropriations Act, 2012
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
340B issues. H.R. 2017, Continuing Appropriations Act, 2012. H.R. 2608, Continuing Appropriations Act, 2012. S. 365/Pub. L. 112-25, Budget Control Act of 2011. H.R. 2674, 340B Program Improvement Act P.L. 111-152 Health Care and Education Reconciliation Act of 2010 implementation. P.L. 111-148 Patient Protection and Affordable Care Act implementation.
Continuing Appropriations Act, 2012
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
FY 2012 budget resolutions. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68 H.J.RES. 94, Continuing Resolution throuh 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. . 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
Continuing Appropriations Act, 2012
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Medicare coverage and reimbursement Monitor debt ceiling negotiations. H.R. 2017, Continuing Appropriations Act, 2012. H.R. 2608, Continuing Appropriations Act, 2012. S. 365/Pub.L. 112-25, Budget Control Act of 2011.
340B Program Improvement Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
340B issues. H.R. 2017, Continuing Appropriations Act, 2012. H.R. 2608, Continuing Appropriations Act, 2012. S. 365/Pub. L. 112-25, Budget Control Act of 2011. H.R. 2674, 340B Program Improvement Act P.L. 111-152 Health Care and Education Reconciliation Act of 2010 implementation. P.L. 111-148 Patient Protection and Affordable Care Act implementation.
340B Program Improvement Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
340B-related issues. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68 H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2674, 340B Program Improvement Act Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
340B Program Improvement Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
340B-related issues. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68 H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2674, 340B Program Improvement Act Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Consolidated Appropriations Act, 2012
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Medicare coverage and reimbursement. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67 H.R.2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011.
Consolidated Appropriations Act, 2012
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Medicare coverage and reimbursement. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67 H.R.2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011.
Consolidated Appropriations Act, 2012
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
340B-related issues. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68 H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2674, 340B Program Improvement Act Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Consolidated Appropriations Act, 2012
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
340B-related issues. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68 H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2674, 340B Program Improvement Act Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Consolidated Appropriations Act, 2012
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
FY 2012 budget resolutions. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68 H.J.RES. 94, Continuing Resolution throuh 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. . 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
Consolidated Appropriations Act, 2012
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
FY 2012 budget resolutions. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68 H.J.RES. 94, Continuing Resolution throuh 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. . 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
340B-related issues. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68 H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2674, 340B Program Improvement Act Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Temporary Payroll Tax Cut Continuation Act of 2011
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
340B-related issues. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68 H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2674, 340B Program Improvement Act Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Temporary Payroll Tax Cut Continuation Act of 2011
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Medicare coverage and reimbursement. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67 H.R.2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
FY 2012 budget resolutions. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68 H.J.RES. 94, Continuing Resolution throuh 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. . 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Medicare coverage and reimbursement. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67 H.R.2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
FY 2012 budget resolutions. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68 H.J.RES. 94, Continuing Resolution throuh 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. . 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
FY 2012 budget resolutions. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68 H.J.RES. 94, Continuing Resolution throuh 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. . 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Medicare coverage and reimbursement. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67 H.R.2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
FY 2012 budget resolutions. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68 H.J.RES. 94, Continuing Resolution throuh 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. . 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Medicare coverage and reimbursement. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67 H.R.2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
340B-related issues. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68 H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2674, 340B Program Improvement Act Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Temporary Payroll Tax Cut Continuation Act of 2011
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
340B-related issues. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68 H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2674, 340B Program Improvement Act Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Comparative Effectiveness H.R. 1 american Rocovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Comparative Effectiveness H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Comparative Effectiveness H.R. 1 american Rocovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Comparative Effectiveness H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85
Making further continuing appropriations for fiscal year 2011, and for other purposes.
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) S. 3686 Labor, Health and Human Services, and Education Appropriations Act, 2011 H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 2011; PL 111-322 H.J.RES.105, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-317 H.J.RES.101, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-290
Making further continuing appropriations for fiscal year 2011, and for other purposes.
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Medicare Issues P.L. 111-148 Patient Protection and Affordable Care Act implementation P.L. 111-152 Health Care and Education Reconciliation Act of 2010 implementation H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) H.R. 4899 Supplemental Appropriations Act, 2010 (AMP Revisions) H.R. 5712 Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Childrens Hospital Provision) S. 11 To restore the application of the 340B drug discount program to orphan drugs with respect to childrens hospitals H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 2011; PL 111-322 H.J.RES.105, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-31 H.J.RES.101, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-290 H.R. 4994, Medicare and Medicaid Extenders Act of 2010; P.L. 111-309 H.R. 5712, The Physician Payment and Therapy Relief Act of 2010; P.L. 111-286
Making further continuing appropriations for fiscal year 2011, and for other purposes.
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) S. 3686 Labor, Health and Human Services, and Education Appropriations Act, 2011 H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 2011; PL 111-322 H.J.RES.105, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-317 H.J.RES.101, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-290
Making further continuing appropriations for fiscal year 2011, and for other purposes.
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Medicare Issues P.L. 111-148 Patient Protection and Affordable Care Act implementation P.L. 111-152 Health Care and Education Reconciliation Act of 2010 implementation H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) H.R. 4899 Supplemental Appropriations Act, 2010 (AMP Revisions) H.R. 5712 Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Childrens Hospital Provision) S. 11 To restore the application of the 340B drug discount program to orphan drugs with respect to childrens hospitals H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 2011; PL 111-322 H.J.RES.105, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-31 H.J.RES.101, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-290 H.R. 4994, Medicare and Medicaid Extenders Act of 2010; P.L. 111-309 H.R. 5712, The Physician Payment and Therapy Relief Act of 2010; P.L. 111-286
Patent Reform Act of 2009
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
S. 515 Patent Reform Act of 2009 S. 610 Patent Reform Act of 2009 H.R. 1260 Patent Reform Act of 2009
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathways for Biosimilars Act s. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathways for Biosimilars Act s. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427 Promoting Innovation and Access to LIfe-Saving Medicine H.R. 1548 Pathways for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427 Promoting Innovation and Access to LIfe-Saving Medicine H.R. 1548 Pathways for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Pathway for Biosimilars Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427 Promoting Innovation and Access to LIfe-Saving Medicine H.R. 1548 Pathways for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Pathway for Biosimilars Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427 Promoting Innovation and Access to LIfe-Saving Medicine H.R. 1548 Pathways for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Pathway for Biosimilars Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathways for Biosimilars Act s. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Pathway for Biosimilars Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathways for Biosimilars Act s. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Medicare and Medicaid Extenders Act of 2010
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
P.L. 111-148 Patient Protection and Affordable Care Act P.L. 111-152 Health Care and Education Reconciliation Act of 2010 H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) H.R. 4994, Medicare and Medicaid Extenders Act of 2010; P.L. 111-309 H.R. 4899 Supplemental Appropriations Act, 2010 (AMP Revisions) H.R. 5712 Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Childrens Hospital Provision) S. 11 To restore the application of the 340B drug discount program to orphan drugs with respect to childrens hospitals H.R. 5712, The Physician Payment and Therapy Relief Act of 2010; P.L. 111-286
Medicare and Medicaid Extenders Act of 2010
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Medicare Issues P.L. 111-148 Patient Protection and Affordable Care Act implementation P.L. 111-152 Health Care and Education Reconciliation Act of 2010 implementation H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) H.R. 4899 Supplemental Appropriations Act, 2010 (AMP Revisions) H.R. 5712 Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Childrens Hospital Provision) S. 11 To restore the application of the 340B drug discount program to orphan drugs with respect to childrens hospitals H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 2011; PL 111-322 H.J.RES.105, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-31 H.J.RES.101, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-290 H.R. 4994, Medicare and Medicaid Extenders Act of 2010; P.L. 111-309 H.R. 5712, The Physician Payment and Therapy Relief Act of 2010; P.L. 111-286
Physician Payment and Therapy Relief Act of 2010
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
P.L. 111-148 Patient Protection and Affordable Care Act P.L. 111-152 Health Care and Education Reconciliation Act of 2010 H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) H.R. 4994, Medicare and Medicaid Extenders Act of 2010; P.L. 111-309 H.R. 4899 Supplemental Appropriations Act, 2010 (AMP Revisions) H.R. 5712 Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Childrens Hospital Provision) S. 11 To restore the application of the 340B drug discount program to orphan drugs with respect to childrens hospitals H.R. 5712, The Physician Payment and Therapy Relief Act of 2010; P.L. 111-286
Physician Payment and Therapy Relief Act of 2010
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Medicare Issues P.L. 111-148 Patient Protection and Affordable Care Act implementation P.L. 111-152 Health Care and Education Reconciliation Act of 2010 implementation H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) H.R. 4899 Supplemental Appropriations Act, 2010 (AMP Revisions) H.R. 5712 Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Childrens Hospital Provision) S. 11 To restore the application of the 340B drug discount program to orphan drugs with respect to childrens hospitals H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 2011; PL 111-322 H.J.RES.105, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-31 H.J.RES.101, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-290 H.R. 4994, Medicare and Medicaid Extenders Act of 2010; P.L. 111-309 H.R. 5712, The Physician Payment and Therapy Relief Act of 2010; P.L. 111-286
Medicare Home Infusion Therapy Coverage Act of 2009
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009
Medicare Home Infusion Therapy Coverage Act of 2009
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009
Medicare Home Infusion Therapy Coverage Act of 2009
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009
Medicare Home Infusion Therapy Coverage Act of 2009
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009
A bill to restore the application of the 340B drug discount program to orphan drugs with respect to children's hospitals.
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Medicare Issues P.L. 111-148 Patient Protection and Affordable Care Act implementation P.L. 111-152 Health Care and Education Reconciliation Act of 2010 implementation H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) H.R. 4899 Supplemental Appropriations Act, 2010 (AMP Revisions) H.R. 5712 Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Childrens Hospital Provision) S. 11 To restore the application of the 340B drug discount program to orphan drugs with respect to childrens hospitals H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 2011; PL 111-322 H.J.RES.105, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-31 H.J.RES.101, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-290 H.R. 4994, Medicare and Medicaid Extenders Act of 2010; P.L. 111-309 H.R. 5712, The Physician Payment and Therapy Relief Act of 2010; P.L. 111-286
A bill to restore the application of the 340B drug discount program to orphan drugs with respect to children's hospitals.
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
P.L. 111-148 Patient Protection and Affordable Care Act P.L. 111-152 Health Care and Education Reconciliation Act of 2010 H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) H.R. 4994, Medicare and Medicaid Extenders Act of 2010; P.L. 111-309 H.R. 4899 Supplemental Appropriations Act, 2010 (AMP Revisions) H.R. 5712 Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Childrens Hospital Provision) S. 11 To restore the application of the 340B drug discount program to orphan drugs with respect to childrens hospitals H.R. 5712, The Physician Payment and Therapy Relief Act of 2010; P.L. 111-286
Medicare Home Infusion Therapy Coverage Act of 2009
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009
Medicare Home Infusion Therapy Coverage Act of 2009
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009
Medicare Home Infusion Therapy Coverage Act of 2009
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009
Medicare Home Infusion Therapy Coverage Act of 2009
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009
Physician Payments Sunshine Act of 2009
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
S.301 Physician Payments Sunshine Act of 2009
Physician Payments Sunshine Act of 2009
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
S.301 Physician Payments Sunshine Act of 2009
Physician Payments Sunshine Act of 2009
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
S.301 Physician Payments Sunshine Act of 2009
Physician Payments Sunshine Act of 2009
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
S.301 Physician Payments Sunshine Act of 2009
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) S. 3686 Labor, Health and Human Services, and Education Appropriations Act, 2011 H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 2011; PL 111-322 H.J.RES.105, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-317 H.J.RES.101, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-290
Patent Reform Act of 2009
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
S. 515 Patent Reform Act of 2009 S. 610 Patent Reform Act of 2009 H.R. 1260 Patent Reform Act of 2009
Patent Reform Act of 2009
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
S. 515 Patent Reform Act of 2009 S. 610 Patent Reform Act of 2009 H.R. 1260 Patent Reform Act of 2009
21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
S.717, 21st Century Cancer ALERT Act Issues related to Medicare coverage for certain cancer therapies Issues related to Comparative Effectiveness
21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
S.717, 21st Century Cancer ALERT Act Issues related to Medicare coverage for certain cancer therapies Issues related to Comparative Effectiveness
21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
S.717, 21st Century Cancer ALERT Act Issues related to Medicare coverage for certain cancer therapies Issues related to Comparative Effectiveness
21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
S.717, 21st Century Cancer ALERT Act Issues related to Medicare coverage for certain cancer therapies Issues related to Comparative Effectiveness
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathways for Biosimilars Act s. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathways for Biosimilars Act s. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427 Promoting Innovation and Access to LIfe-Saving Medicine H.R. 1548 Pathways for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427 Promoting Innovation and Access to LIfe-Saving Medicine H.R. 1548 Pathways for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Fairness for Homeowners Act of 2007
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
P.L. 111-148 Patient Protection and Affordable Care Act P.L. 111-152 Health Care and Education Reconciliation Act of 2010 H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) H.R. 4994, Medicare and Medicaid Extenders Act of 2010; P.L. 111-309 H.R. 4899 Supplemental Appropriations Act, 2010 (AMP Revisions) H.R. 5712 Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Childrens Hospital Provision) S. 11 To restore the application of the 340B drug discount program to orphan drugs with respect to childrens hospitals H.R. 5712, The Physician Payment and Therapy Relief Act of 2010; P.L. 111-286
Fairness for Homeowners Act of 2007
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) S. 3686 Labor, Health and Human Services, and Education Appropriations Act, 2011 H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 2011; PL 111-322 H.J.RES.105, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-317 H.J.RES.101, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-290
Fairness for Homeowners Act of 2007
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Medicare Issues P.L. 111-148 Patient Protection and Affordable Care Act implementation P.L. 111-152 Health Care and Education Reconciliation Act of 2010 implementation H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) H.R. 4899 Supplemental Appropriations Act, 2010 (AMP Revisions) H.R. 5712 Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Childrens Hospital Provision) S. 11 To restore the application of the 340B drug discount program to orphan drugs with respect to childrens hospitals H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 2011; PL 111-322 H.J.RES.105, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-31 H.J.RES.101, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-290 H.R. 4994, Medicare and Medicaid Extenders Act of 2010; P.L. 111-309 H.R. 5712, The Physician Payment and Therapy Relief Act of 2010; P.L. 111-286
Montgomery GI Bill Degree Extension Act of 2007
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) S. 3686 Labor, Health and Human Services, and Education Appropriations Act, 2011 H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 2011; PL 111-322 H.J.RES.105, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-317 H.J.RES.101, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-290
Montgomery GI Bill Degree Extension Act of 2007
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Medicare Issues P.L. 111-148 Patient Protection and Affordable Care Act implementation P.L. 111-152 Health Care and Education Reconciliation Act of 2010 implementation H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) H.R. 4899 Supplemental Appropriations Act, 2010 (AMP Revisions) H.R. 5712 Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Childrens Hospital Provision) S. 11 To restore the application of the 340B drug discount program to orphan drugs with respect to childrens hospitals H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 2011; PL 111-322 H.J.RES.105, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-31 H.J.RES.101, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-290 H.R. 4994, Medicare and Medicaid Extenders Act of 2010; P.L. 111-309 H.R. 5712, The Physician Payment and Therapy Relief Act of 2010; P.L. 111-286
Community-Based Mental Health Infrastructure Improvements Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
P.L. 111-148 Patient Protection and Affordable Care Act P.L. 111-152 Health Care and Education Reconciliation Act of 2010 H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) H.R. 4994, Medicare and Medicaid Extenders Act of 2010; P.L. 111-309 H.R. 4899 Supplemental Appropriations Act, 2010 (AMP Revisions) H.R. 5712 Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Childrens Hospital Provision) S. 11 To restore the application of the 340B drug discount program to orphan drugs with respect to childrens hospitals H.R. 5712, The Physician Payment and Therapy Relief Act of 2010; P.L. 111-286
Community-Based Mental Health Infrastructure Improvements Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Medicare Issues P.L. 111-148 Patient Protection and Affordable Care Act implementation P.L. 111-152 Health Care and Education Reconciliation Act of 2010 implementation H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) H.R. 4899 Supplemental Appropriations Act, 2010 (AMP Revisions) H.R. 5712 Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Childrens Hospital Provision) S. 11 To restore the application of the 340B drug discount program to orphan drugs with respect to childrens hospitals H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 2011; PL 111-322 H.J.RES.105, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-31 H.J.RES.101, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-290 H.R. 4994, Medicare and Medicaid Extenders Act of 2010; P.L. 111-309 H.R. 5712, The Physician Payment and Therapy Relief Act of 2010; P.L. 111-286
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Comparative Effectiveness H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Comparativ Effectiveness H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Comparative Effectiveness H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Comparative Effectiveness H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Comparative Effectiveness H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathways for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H. R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathways for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathways for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Promoting Innovation and Access to Life-Saving Medicine Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathways to Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Pathway for Biosimilars Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathways for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Pathway for Biosimilars Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathways to Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Pathway for Biosimilars Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathways for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Pathway for Biosimilars Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H. R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Pathway for Biosimilars Act
Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY · Firm: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathways for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
340B-related issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2012 (implemention).
Prescription Drug User Fee Act reauthorization. Product exclusivity issues; pedigree issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY via MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
2012 · first_quarter · Q1
340B-related issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
FY 2013 budget resolutions. H. Con. Res 112, Establishing the budget for the US Government for FY 2013.
Prescription Drug User Fee Act reauthorization. Product exclusivity issues; pedigree issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation) Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Medicare coverage and reimbursement H. Con. Res 112, Establishing the budget for the US Government for FY 2013.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY via MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
2011 · fourth_quarter · 4A
Medicare coverage and reimbursement. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67 H.R.2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011.
Prescription Drug User Fee Act reauthorization. Product exclusivity issues. S. 365/Pub. L. 112-25, Budget Control Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implemention)
340B-related issues. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68 H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2674, 340B Program Improvement Act Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
FY 2012 budget resolutions. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68 H.J.RES. 94, Continuing Resolution throuh 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. . 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY via MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
2011 · fourth_quarter · Q4
Prescription Drug User Fee Act reauthorization. Product exclusivity issues. S. 365/Pub. L. 112-25, Budget Control Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implemention)
Medicare coverage and reimbursement. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68. H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67 H.R.2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011.
340B-related issues. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68 H.J.RES. 94, Continuing Resolution through 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. L. 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2674, 340B Program Improvement Act Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
FY 2012 budget resolutions. H.R. 2055 and H.R. 3671, Consolidated Appropriations Act of 2011, Pub. L. 112-74. H.J.RES. 95, Continuing Resolution through 12/23/11, Pub. L. 112-68 H.J.RES. 94, Continuing Resolution throuh 12/17/11, Pub. L. 112-67. H.R. 2608, Continuing Appropriations Act, 2012, Pub. L. 122-36. H.R. 3765, Temporary Payroll Tax Cut Continuation of 2011, Pub. . 112-78. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 3743, Middle Class Tax Relief and Job Creation Act of 2011. H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY via MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
2011 · third_quarter · Q3
Medicare coverage and reimbursement Monitor debt ceiling negotiations. H.R. 2017, Continuing Appropriations Act, 2012. H.R. 2608, Continuing Appropriations Act, 2012. S. 365/Pub.L. 112-25, Budget Control Act of 2011.
H.R. 1249/S.23, America Invents Act
Prescription Drug User Fee Act reauthorization. Product exclusivity issues. S. 365/Pub. L. 112-25, Budget Control Act of 2011. H.R. 2112, Agriculture Appropriations. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
FY 2012 Budget resolutions H.R. 2017, Continuing Appropriations Act, 2012. H.R. 2608, Continuing Appropriations Act, 2012. S. 365/Pub. L. 112-25, Budget Control Act of 2011.
340B issues. H.R. 2017, Continuing Appropriations Act, 2012. H.R. 2608, Continuing Appropriations Act, 2012. S. 365/Pub. L. 112-25, Budget Control Act of 2011. H.R. 2674, 340B Program Improvement Act P.L. 111-152 Health Care and Education Reconciliation Act of 2010 implementation. P.L. 111-148 Patient Protection and Affordable Care Act implementation.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY via MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
2011 · second_quarter · Q2
Patient Protection and Affordable Care Act implementation. P.L. 111-148 Patient Protection and Affordable Care Act implementation. P.L. 111-152 Health Care and Education Reconciliation Act of 2010 implementation. 340B issues.
Medicare Coverage and reimbursement. P.L. 111-148 Patient Protection and Affordable Care Act implementation. PL. 111-152 Health Care and Education Reconciliation Act of 2010 implementation.
H.R. 1249/S.23, America Invents Act.
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY via MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
2011 · first_quarter · Q1
Prescription Drug User Fee Act reauthorization.
Patient Protection and Affordable Care Act implementation. P.L. 111-148 Patient Protection and Affordable Care Act implementation. P.L. 111-152 Health Care and Education Reconciliation Act of 2010 implementation. 340B issues.
Medicare Coverage and reimbursement. P.L. 111-148 Patient Protection and Affordable Care Act implementation. PL. 111-152 Health Care and Education Reconciliation Act of 2010 implementation.
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY via MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
2010 · fourth_quarter · Q4
Drug Safety/Pedigree Bills P.L. 111-148 Patient Protection and Affordable Care Act P.L. 111-152 Health Care and Education Reconciliation Act of 2010
Medicare Issues P.L. 111-148 Patient Protection and Affordable Care Act implementation P.L. 111-152 Health Care and Education Reconciliation Act of 2010 implementation H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) H.R. 4899 Supplemental Appropriations Act, 2010 (AMP Revisions) H.R. 5712 Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Childrens Hospital Provision) S. 11 To restore the application of the 340B drug discount program to orphan drugs with respect to childrens hospitals H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 2011; PL 111-322 H.J.RES.105, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-31 H.J.RES.101, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-290 H.R. 4994, Medicare and Medicaid Extenders Act of 2010; P.L. 111-309 H.R. 5712, The Physician Payment and Therapy Relief Act of 2010; P.L. 111-286
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY via MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
2010 · third_quarter · 3A
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathways for Biosimilars Act s. 726 Promoting Innovation and Access to Life-Saving Medicine Act
S.717, 21st Century Cancer ALERT Act Issues related to Medicare coverage for certain cancer therapies Issues related to Comparative Effectiveness
S.301 Physician Payments Sunshine Act of 2009
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY via MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
2010 · third_quarter · Q3
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathways for Biosimilars Act s. 726 Promoting Innovation and Access to Life-Saving Medicine Act
H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009
S.717, 21st Century Cancer ALERT Act Issues related to Medicare coverage for certain cancer therapies Issues related to Comparative Effectiveness
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY via MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
2010 · second_quarter · Q2
Comparative Effectiveness H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85
S.301 Physician Payments Sunshine Act of 2009
S.717, 21st Century Cancer ALERT Act Issues related to Medicare coverage for certain cancer therapies Issues related to Comparative Effectiveness
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY via MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
2010 · first_quarter · Q1
S.717, 21st Century Cancer ALERT Act Issues related to Medicare coverage for certain cancer therapies Issues related to Comparative Effectiveness
S.301 Physician Payments Sunshine Act of 2009
Comparative Effectiveness H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY via MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
2009 · fourth_quarter · Q4
Comparativ Effectiveness H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85
S.717, 21st Century Cancer ALERT Act Issues related to Medicare coverage for certain cancer therapies Issues related to Comparative Effectiveness
H.R. 574 Medicare Home Infusion Therapy/Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY via MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
2009 · third_quarter · Q3
H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009
S. 301 Physician Payments Sunshine Act of 2009
S.717, 21st Century Cancer ALERT Act Issues related to Medicare coverage for certain cancer therapies Issues related to Comparative Effectiveness
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY via MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
2009 · third_quarter · Q3
Medicare issues S. 301 Physician Payments Sunshine Act of 2009
S.717, 21st Century Cancer ALERT Act Issues related to Medicare coverage for certain cancer therapies Issues related to Comparative Effectiveness
Comparative Effectiveness H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY via MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
2009 · second_quarter · Q2
S.717, 21st Century Cancer ALERT Act Issues relaed to Medicare coverage for certain cancer therapies. Issues related to Comparative Effectiveness.
Medicare issues S. 301 Physician Payments Sunshine Act of 2009
H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY via MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
2009 · first_quarter · Q1
Medicare issues S. 301 Physician Payments Sunshine Act of 2009
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H. R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
S.717, 21st Century Cancer ALERT Act Issues related to Medicare coverage for certain cancer therapies. Issues related to Comparative Effectiveness.
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY via MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
2008 · fourth_quarter · Q4
Medicare/Medicaid and other general health issues
S. 1145, Patent Reform Act of 2007, entire bill H.R. 1908, Patent Reform Act of 2007, entire bill S. 3600, Patent Reform Act of 2008, entire bill
House Concurrent Resolution 312 FY09 Budget Resolution Senate Concurrent Resolution 70 FY09 Budget Resolution Drug Importation Comparative Effectiveness LHHS Appropriations Homeland Appropriations Agriculture Appropriations
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY via MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
2008 · third_quarter · Q3
H. R. 5480, Medicare Funding Warning Response Act of 2008 S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions 2008 Medicare Bill Comparative Effectiveness H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008 H.4, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions
Issues related to Medicare coverage for certain cancer therapies Issues related to Comparative Effectiveness
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY via MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
2008 · second_quarter · Q2
Medicare/Medicaid and other general health issues.
Issues related to Medicare coverage for certain cancer therapies Issues related to Comparative Effectiveness
S. 1145, Patent Reform Act of 2007, entire bill H.R. 1908, Patent Reform Act of 2007, entire bill
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY via MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
2008 · third_quarter · RA
H. R. 5480, Medicare funding Warning Response Act of 2008 S. 2029, Physician Payments Sunshine Act of 2007 H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics S. 1145, Patent Reform Act of 2007, entire bill
H. R. 5480, Medicare funding Warning Response Act of 2008 S. 2029, Physician Payments Sunshine Act of 2007 H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics S. 1145, Patent Reform Act of 2007, entire bill
H. R. 5480, Medicare funding Warning Response Act of 2008 S. 2029, Physician Payments Sunshine Act of 2007 H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics S. 1145, Patent Reform Act of 2007, entire bill
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY via MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
2008 · first_quarter · Q1
H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 5629, Pathway for Biosimilars Act S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 623, Access to Life-Saving Medicine Act, follow-on biologics
S. 1145, Patent Reform Act of 2007, entire bill HR. 1908, Patent Reform Act of 2007, entire bill
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY via MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
2007 · year_end · YY
PDUFA-IV Biologics FDA Appropriations
HR 2795 Patent Reform Act of 2005
Medicare Part B coverage issues Section 1861 (t)(2)(B) Social Security Act H.R. 3162, Children's Health and Medicare Protection Act
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
FY 2012 Budget resolutions.
Prescription Drug User Fee Act reauthorization.
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
H.R. 1249/S.23, America Invents Act.
FY 2012 Budget resolutions.
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) S. 3686 Labor, Health and Human Services, and Education Appropriations Act, 2011 H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 2011; PL 111-322 H.J.RES.105, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-317 H.J.RES.101, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-290
P.L. 111-148 Patient Protection and Affordable Care Act P.L. 111-152 Health Care and Education Reconciliation Act of 2010 H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) H.R. 4994, Medicare and Medicaid Extenders Act of 2010; P.L. 111-309 H.R. 4899 Supplemental Appropriations Act, 2010 (AMP Revisions) H.R. 5712 Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Childrens Hospital Provision) S. 11 To restore the application of the 340B drug discount program to orphan drugs with respect to childrens hospitals H.R. 5712, The Physician Payment and Therapy Relief Act of 2010; P.L. 111-286
S. 515 Patent Reform Act of 2009 S. 610 Patent Reform Act of 2009 H.R. 1260 Patent Reform Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009
Comparative Effectiveness H.R. 1 american Rocovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Comparative Effectiveness H.R. 1 american Rocovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85
S.301 Physician Payments Sunshine Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009
H.R. 1427 Promoting Innovation and Access to LIfe-Saving Medicine H.R. 1548 Pathways for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 1427 Promoting Innovation and Access to LIfe-Saving Medicine H.R. 1548 Pathways for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare issues S. 301 Physician Payments Sunshine Act of 2009
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathways to Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathways for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Comparative Effectiveness H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathways for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathways for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Comparative Effectiveness H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009
Comparative Effectiveness H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 5480, Medicare Funding Warning Response Act of 2008 S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions 2008 Medicare Bill Comparative Effectiveness H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008 H.R, Medicare Prescription Drug Price Negotiation Act, Medicare noninterfeence provisions H.R. 1424, Emergency Economic Stabilization Act of 2008 H.R. 3162, Children's Health and Medicare Protection Act of 2007; S. 1893-SCHIP
H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection Innovative Biologic Medicine Act of 2007, follow-on biologics H.R. 5629, Pathway for Biosimilars Act S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 623, Access to Life-Saving Medicine Act, follow-on biologics
Issues related to Medicare coverage for certain cancer therapies Issues related to Comparative Effectiveness
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Medicare/Medicaid and other general health issues
H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicine Act of 2007, follow-on biologics H. R. 5629, Pathway for Biosimilars Act S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S.1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 623, Access to Life-Saving Medicine Act, follow-on biologics
S. 1145, Patent Reform Act of 2007, entire bill H.R. 1908, Patent Reform Act of 2007, entire bill
House Concurrent Resolution 312 FY09 Budget Resolution Senate Concurrent Resolution 70 FY09 Budget Resolution Drug Importation Comparative Effectiveness LHHS Appropriations Homeland Appropriations Agriculture Appropriations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 5629, Pathway for Biosimilars Act S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 623, Access to Life-Saving Medicine Act, follow-on biologics
House Concurrent Resolution 312 FY09 Budget Resolution Senate Concurrent Resolution 70 FY09 Budget Resolution Drug Importation Comparative Effectiveness LHHS Appropriations Homeland Appropriations Agriculture Appropriations
H.R. 5480, Medicare Funding Warning Response Act of 2008 S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions 2008 Medicare Bill Comparative Effectiveness H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008 H.4, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H. R. 5480, Medicare funding Warning Response Act of 2008 S. 2029, Physician Payments Sunshine Act of 2007 H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics S. 1145, Patent Reform Act of 2007, entire bill
H. R. 5480, Medicare funding Warning Response Act of 2008 S. 2029, Physician Payments Sunshine Act of 2007 H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics S. 1145, Patent Reform Act of 2007, entire bill
H. R. 5480, Medicare funding Warning Response Act of 2008 S. 2029, Physician Payments Sunshine Act of 2007 H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics S. 1145, Patent Reform Act of 2007, entire bill
S.2499, Medicare, Medicaid, and SCHIP Extension Act of 2007, S.1893 Issues related to Medicare coverage for certain cancer therapies Issues related to Compartive Effectiveness Medicare/Medicaid and other general health issues, H.R. 3162
House Concurrent Resolution 312 FY09 Budget Resolution Senate Concurrent Resolution 70 FY09 Budget Resolution Drug Importation Comparative Effectiveness LHHS Appropriations Homeland Appropriations Agriculture Appropriations
Medicare/Medicaid and other general health issues
H.R. 3162 Children's Health and Medicare Protection Act of 2007 H. 4, Medicare Prescription Drug Price Negotiation Act, Meicare noninterference provisions H. R. 5480, Medicare Funding Warning Response Act of 2008 S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions 2008 Medicare Bill Comparative Effectiveness
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE